Skip to main content



Local Cdiff information for Georgia

Georgia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.



Local Cdiff information for Georgia

Georgia

Learn about C. diff providers, regulation, clinical trials, and advocacy efforts in Georgia.

Providers

Nirja Mehta, MD, MS

Emory University Hospital Midtown Campus
550 Peachtree Street Northeast
Medical Office Tower, Fl 7
Atlanta, GA 30308

(404) 686-8114

VISIT WEBSITE>

 

Dr. Ravi Kamepalli, MD

Regional Infectious Diseases and Infusion Center, Inc.
505 Jenkins St
LaGrange, 30240
706-739-7789
FMT Provider: Yes
VISIT WEBSITE >

Dr. Colleen Kraft, MD Assistant Professor, Pathology & Laboratory Medicine

Emory Clinic at 1365 Clifton Road
1365 Clifton Road NE
Atlanta, 30322
404-686-8114
EMAIL DR. KRAFT >
FMT Provider: Yes
VISIT WEBSITE >

Regulation

C. diff Infections

Total Reported Cases: 2203
Hospital Onset: 2203
Community Onset: Not reported
Related Deaths: Not reported

Available Reports

Annual Progress based on SIR: 0.67
CDC STATE PROGRESS REPORT >
STATE REPORTING >

State Reporting Laws

Data Submission Required: Yes
Data Publicly Available: No
Data Validated: No
Facility-specific Data Publicly Reported: No
LTC Facility Submission Required: No
LTC Facility Data Publicly Reported: No
Law/Regulation: Not available
STATUTE >

State Contact

Jeanne Negley, MBA
HAI Surveillance Program Director
Georgia Department of Community Health
Division of Public Health Acute Disease Epidemiology Section
2 Peachtree Street NW, #14-225
Atlanta, 30303
(404) 657-2593
(404) 657-7517
EMAIL JEANNE NEGLEY, MBA >

CLINICAL TRIALS

OpTION

Official Title: CSP #596 – Optimal Treatment for Recurrent Clostridium Difficile Infection
Trial No. NCT02667418
Type: Interventional
Recruitment: Recruiting
Sponsor: VA Office of Research and Development
Contact: Michelle Johnson
(708) 202-8387 ext 27001
EMAIL
Gender: All
Age: 18 Years and older

ROAR

Official Title: REBYOTA™ for the Prevention of Recurrence of Clostridioides Difficile Infection (CDI) in Adult Patients: An Observational Study
Trial No. NCT05835219
Type: Observational
Recruitment: Recruiting
Sponsor: Ferring Pharmaceuticals
Contact: Global Clinical Compliance
833-548-1402
EMAIL
Gender: All
Age: 18 Years and older

RESTORATiVE303

Official Title: A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Trial No. NCT06237452
Type: Interventional
Recruitment: Recruiting
Sponsor: Vedanta Biosciences, Inc
Contact: Mary Garfield
EMAIL >
Gender: All
Age: 12 Years and older
Vedanta Biosciences has teamed up with Science37 to provide a site-less, decentralized approach. This means the study can be done remotely and the product comes to you, in your home. This allows applicants who are not near a study site or unable to travel to participate and receive treatment. You can sign up for the decentralized study here.